Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

SAN JOSE, California, December 10 /PRNewswire/ --

Micrel Inc., (Nasdaq: MCRL), an industry leader in analog, high bandwidth communications and Ethernet IC solutions, today launched a tiny new high performance, high PSRR, ultra-low dropout (ULDO(TM)) linear regulator family with input voltage down to 1.6V for high efficiency portable devices such as mobile phones, PDAs, portable media players (PMP), GPS and other portable device applications. The MIC5308 is currently available in volume with pricing starting at US$0.49 for 1K quantities. The MIC5309 is also currently available in volume at US$0.53 in 1K quantities.

CAMBRIDGE, England, December 10 /PRNewswire/ --

- ARM Cortex-A8 Processor and ARM11 MPCore Multiprocessor Cores to Power ASIC Solutions and Passive Optical Network Devices

ARM ((LSE:ARM); (Nasdaq:ARMHY)) today announced that PMC-Sierra, Inc. (Nasdaq:PMCS), a leading provider of broadband communications and storage semiconductors, has licensed the high-performance ARM(R) Cortex(tm)-A8 processor and ARM11(tm) MPCore(tm) multicore processor for a broad range of designs, including devices for Passive Optical Networks (PON) and ASIC devices.

WASHINGTON, December 10 /PRNewswire/ --

- Leading technology companies join forces to improve access to technology.

A coalition of leading information and assistive technology companies today announced the formation of the Accessibility Interoperability Alliance (AIA), an engineering working group dedicated to enabling developers to more easily create accessible software, hardware and Web products. Those solutions will reduce barriers to information and communication technologies that currently exist for people with disabilities in today's increasingly digital world.

(Photo: http://www.newscom.com/cgi-bin/prnh/20000822/MSFTLOGO)

SAN JOSE, California, December 10 /PRNewswire/ --

- Full Featured, Extensible Wowza Media Server(TM) Pro Unlimited is Already Proclaimed 'the Smart Choice' by Customers Worldwide

Wowza Media Systems, emerging leader in media streaming server software, today made Flash streaming even more affordable with an 80% price reduction for its widely popular Wowza Media Server Pro Unlimited. Now priced at US$995, Wowza once again reaffirmed its price leadership on a mission to make flash streaming server technology affordable to all.

LONDON, December 10 /PRNewswire/ -- Misys (FTSE: MSY.L), the global application software and services company, announced today that AB Bank Limited, the first private sector bank of Bangladesh, has gone live with Equation 3.8.2 and Misys Trade Innovation.

The integrated solution from Misys will underpin the bank's restructure and will centralise processes, bring automation and enhance customer service throughout the 70 domestic branches and foreign branches in India.

The bank has seen sustained growth since forming and recently completed its silver jubilee in August 2007. It needed to remove some of the legacy systems and centralise on a single solution to update the business processes at the bank and bring more value to its consumer and corporate customers.

BASEL, Switzerland, December 10 /PRNewswire/ --

- Phase II Results Suggest Avastin Can be Used in Curative Setting Date

Experts attending the 30th San Antonio Breast Cancer Symposium (SABCS) December 13-16, will be amongst the first to hear new data that highlight further advances in the treatment of breast cancer with Avastin, Herceptin, pertuzumab and Xeloda.